Stock Returns < -44.11 % Than Nifty in last one year
Very Low Dividend Yield of 0.390 %
Book value is negative
Negative Net Margin MRQ
Terrific Steady Risky Stock View - Fundamental Snapshot
Share Overview
Promoter Owned
64.20 %
Institution Owned
0.600 %
Public/Others
35.20 %
Outstanding Shares
8.47 Cr
Floating Shares
2.25 Cr
Floating / Outstanding
26.60%
Book Value/Share
55.55
Face value
1.00
Share Holding
Annual Key Income Statement of SMSPHARMA
Period
31_Mar_2022
31_Mar_2021
Growth
Net Income From Continuing Ops
67.88
60.96
11.35 %
Net Income
62.22
62.53
0.496 %
Operating Income
63.30
87.67
27.80 %
Total Revenue
519.87
563.18
7.69 %
Operating Expense
456.57
475.51
3.98 %
Interest Expense
18.88
11.16
69.18 %
Tax Expense
0.620
30.16
97.94 %
Income Before tax
68.50
91.12
24.82 %
Gross Profit
189.38
181.43
4.38 %
Dividend Paid
-2.54
-2.54
0 %
Quarterly Key Income Statement of SMSPHARMA
Period
30_Sep_2022
30_Jun_2022
Growth
Net Income From Continuing Ops
0.730
-12.77
105.72 %
Net Income
-2.01
-12.77
84.26 %
Operating Income
5.47
-8.74
162.59 %
Total Revenue
159.43
64.39
147.60 %
Operating Expense
145.87
73.13
99.47 %
Interest Expense
5.24
4.85
8.04 %
Tax Expense
0.110
-2.60
104.23 %
Income Before tax
0.840
-12.79
106.57 %
Gross Profit
30.23
15.57
94.16 %
Dividend Paid
0
0
%
Key Balance Sheet Fields
Period
31_Mar_2022
31-Mar-21
Growth
Common Stock
8.47
8.47
0 %
Current Liabilities
196.29
194.09
1.13 %
Total Liabilities
389.22
401.68
3.10 %
Current Assets
377.05
309.33
21.89 %
Total Assets
859.50
812.21
5.82 %
Working capital
180.76
115.24
56.86 %
Accounts Payable
72.86
65.44
11.34 %
Inventory
251.10
137.79
82.23 %
Net Receivable
48.52
105.68
54.09 %
Key Cash Flow Fields
Period
31_Mar_2022
31_Mar_2021
Growth
Cash EPS
11.82
9.83
20.24 %
Cash From Investment Activity
-151.59
-42.56
256.18 %
Cash From Financial Activity
92.02
-2.40
3934.17 %
Cash Operational Activity
90.45
39.71
127.78 %
Net Cash Flow
30.88
-5.25
688.19 %
NetIncome
62.22
62.53
0.496 %
Capital Expenditure
27.25
151.75
82.04 %
Change To Inventory
-113.31
-8.59
1219.09 %
About SMS Pharmaceuticals Limited SMS Pharmaceuticals Limited manufactures and sells active pharmaceutical ingredients (APIs) and intermediates in India. The company offers anti-ulcer, anti-fungal, anti-migraine, anti-diabetic, erectile dysfunction, antiemetic, antiepileptic, antipsychotic, anti-hypertensive, anti-anginal, anti-viral, urinary antispasmodic, and anti-retroviral APIs. It is also involved in the contract research activities. The company also exports its products. SMS Pharmaceuticals Limited was incorporated in 1987 and is based in Hyderabad, India.
TSR Tech Strength is based on Deep Analysis, Back Testing and Historical Trend Analysis using Machine Learning. Overall Technical Strength is based on 50+ indicators including Technicals, moving Avg, chart patterns, candlestick and proprietary algorithms.Technical Strength is calculate from 5Mins Ticck to One Month Tick
TSR Growth analyses dozen of Historical , MRQ, TTM parameters, returns of Individual Stocks vis-a-vis sector , broad based Index to access Growth Potential
TSR Value analyses dozen of Historical , MRQ, TTM parameters, returns of Individual Stocks vis-a-vis sector , broad based Index to access its value
This is an automated process and in NO WAY should be considered as a tip as its based on past data. We strongly recommend to use these signals for information only and seek advise from a certified professional for any trading decision.If you like it then please share. The more the visitors the more the innovations. Feedback
We are working on fundamental strength also. Please share your views to help shape up the requirement.
